regional anaesthesia and thromboprophylaxis dr kate fogg royal brompton hospital
TRANSCRIPT
Regional Anaesthesia and Regional Anaesthesia and ThromboprophylaxisThromboprophylaxis
Dr Kate FoggDr Kate Fogg
Royal Brompton HospitalRoyal Brompton Hospital
Regional AnaesthesiaRegional Anaesthesia
Epidural/spinalEpidural/spinalRisks/benefitsRisks/benefits
• ThromboprophylaxisThromboprophylaxiss/c heparin s/c heparin (unfractionated/LMWH)(unfractionated/LMWH)
anti-Xa or direct thrombin inhibitorsanti-Xa or direct thrombin inhibitors
antiplatelet agentsantiplatelet agentswarfarinwarfarinsystemic heparinisationsystemic heparinisation
Can you put the two together or should you stop one in order to Can you put the two together or should you stop one in order to perform the other?perform the other?
Regional blocksRegional blocks
Drug administered directly to the spinal Drug administered directly to the spinal cord to locally block afferent and efferent cord to locally block afferent and efferent nerve input.nerve input.
Usually for major thoracic, abdominal and Usually for major thoracic, abdominal and lower limb surgerylower limb surgery
Local anaesthetic +/- opiatesLocal anaesthetic +/- opiates
SpinalSpinal
Dural punctureDural punctureSingle shot usuallySingle shot usually24-26G needle, pencil point24-26G needle, pencil pointLess traumaticLess traumaticCatheter rarelyCatheter rarely
EpiduralEpidural
Larger needle – 16 GLarger needle – 16 GLoss of resistance techniqueLoss of resistance techniqueEpidural vesselsEpidural vesselsUsually a catheter techniqueUsually a catheter techniqueTrauma may be on insertion or removal of Trauma may be on insertion or removal of
cathetercatheter
BenefitsBenefits
Improved analgesia, greater mobility, Improved analgesia, greater mobility, fewer opiate side-effectsfewer opiate side-effects
Decrease stress responseDecrease stress response
adverse cardiac, pulmonary and immune adverse cardiac, pulmonary and immune outcomesoutcomes
hypercoagulable statehypercoagulable state
• Decrease troponin release in cardiac Decrease troponin release in cardiac patientspatients
• ? Does this translate into clinical benefit? Does this translate into clinical benefit
Most impressive in high-risk patients Most impressive in high-risk patients undergoing major surgeryundergoing major surgery
Decrease blood loss and transfusion requirementDecrease blood loss and transfusion requirement Decrease thromboembolic complicationsDecrease thromboembolic complications Decrease pneumonia and resp depressionDecrease pneumonia and resp depression Decrease MI and ARFDecrease MI and ARF Decrease mortalityDecrease mortality
RisksRisks
FailureFailureDural TapDural TapCatheter migration subdurallyCatheter migration subdurallyNerve damageNerve damageEpidural abscessEpidural abscessEpidural HaematomaEpidural Haematoma
HaematomaHaematoma
Rare but potentially catastrophicRare but potentially catastrophic Tryba (1993) – 1:150,000 epidural anaesthetics, Tryba (1993) – 1:150,000 epidural anaesthetics,
1:220,000 spinals 1:220,000 spinals (review 1.5 million patients) Risk probably (review 1.5 million patients) Risk probably higher if on drugs altering coagulationhigher if on drugs altering coagulation
Vandermeulen (1994) review for case reports of Vandermeulen (1994) review for case reports of haematomahaematoma
75% associated with epidural, 25% spinal75% associated with epidural, 25% spinal 87% coagulation abnormalities/technical difficulties87% coagulation abnormalities/technical difficulties Coag abnormalities include alcohol abuse, CRF, thrombocytopaenia Coag abnormalities include alcohol abuse, CRF, thrombocytopaenia
as well as drugsas well as drugs
SymptomsSymptoms
Sharp back painSharp back painNew motor/sensory lossNew motor/sensory lossUrinary retentionUrinary retentionVariable and may be confused with effect Variable and may be confused with effect
of LAof LAParaplegiaParaplegiaNeed surgery within 8 hrs to get good Need surgery within 8 hrs to get good
or partial recovery.or partial recovery.
Putting the two together?Putting the two together?
• 1993 LMWH in USA b.d unlike in Europe 1993 LMWH in USA b.d unlike in Europe o.d –sudden increase in reports of o.d –sudden increase in reports of haematoma.haematoma.
• American Society of Regional anaesthesia American Society of Regional anaesthesia and Pain Medicine – Consensus and Pain Medicine – Consensus Statement ,2002Statement ,2002
German Society of Anaesthesia and German Society of Anaesthesia and Intensive Care Medicine 2004Intensive Care Medicine 2004
Unfractionated heparinUnfractionated heparin
Vascular or cardiac casesVascular or cardiac casesAvoid if other coagulopathyAvoid if other coagulopathyHeparin delayed for 1hour after needle Heparin delayed for 1hour after needle
placementplacementCatheter removal 2-4 hr after last heparinCatheter removal 2-4 hr after last heparinPost-op monitoring for at least 48 hrsPost-op monitoring for at least 48 hrs
CardiacCardiac
Does the benefit outweigh the risk?Does the benefit outweigh the risk? Can show less troponin releaseCan show less troponin release Consistent decrease in ventilator timeConsistent decrease in ventilator time Better analgesia on day 1Better analgesia on day 1 ?fewer pulmonary complications?fewer pulmonary complications No consistent improvement in No consistent improvement in
arrythmia/cardiac/renal/neurologic outcomearrythmia/cardiac/renal/neurologic outcome No effect on mortalityNo effect on mortality
Recent case reports of haematomasRecent case reports of haematomasCan achieve other benefits with beta Can achieve other benefits with beta
blockers/multimodal analgesic techniquesblockers/multimodal analgesic techniques?only in high risk COPD patients or those ?only in high risk COPD patients or those
elderly at high risk of confusionelderly at high risk of confusion
LMWHLMWH
Dose dependent antithrombotic effect by Dose dependent antithrombotic effect by anti-Xa inhibitionanti-Xa inhibition
Anti-Xa level not predictive of bleedingAnti-Xa level not predictive of bleedingBeware antiplatelet or oral anticoagulantBeware antiplatelet or oral anticoagulantNeedle placement 10-12 hours after last Needle placement 10-12 hours after last
dose LMWHdose LMWHHigher dose….wait 24hrsHigher dose….wait 24hrs
Post-op:Post-op:Catheter technique safeCatheter technique safeB.D dosing; remove catheter beforehand. B.D dosing; remove catheter beforehand.
Wait 2hrs after catheter removal before Wait 2hrs after catheter removal before first dosefirst dose
O.D. can have indwelling catheter. O.D. can have indwelling catheter. Remove minimum of 10-12 hours after last Remove minimum of 10-12 hours after last dose. Subsequent dose minimum 2hrs dose. Subsequent dose minimum 2hrs laterlater
Oral anticoagulantsOral anticoagulants
Stop 4-5 days beforeStop 4-5 days beforePT/INR within normal limitsPT/INR within normal limits If on low dose post-op need to monitor If on low dose post-op need to monitor
INR dailyINR dailyCatheter removal when INR<1.5Catheter removal when INR<1.5
Antiplatelet medicationsAntiplatelet medications
Include: aspirin, NSAIDs, thienopyridine Include: aspirin, NSAIDs, thienopyridine derivatives (ticlodipine/clopidogrel), GP IIb/IIIa derivatives (ticlodipine/clopidogrel), GP IIb/IIIa antagonists (abciximab/tirofiban)antagonists (abciximab/tirofiban)
GPIIb/IIIa in acute coronary syndrome….unlikely to be heading for GPIIb/IIIa in acute coronary syndrome….unlikely to be heading for surgery where epidural neededsurgery where epidural needed
No wholly accepted test to guide antiplatelet No wholly accepted test to guide antiplatelet therapytherapy
CLASP study in obstetric patients – aspirin CLASP study in obstetric patients – aspirin alonealone does not increase riskdoes not increase risk
NSAID NSAID alonealone no increased risk no increased risk
Actual risk of haematoma with clopidogrel Actual risk of haematoma with clopidogrel etc unknown.etc unknown.
Based on half-lives etc…Based on half-lives etc…Stop ticlodipine 14 days, clopidogrel 7 Stop ticlodipine 14 days, clopidogrel 7
daysdaysGPIIb/IIIa contraindicated with 4 weeksGPIIb/IIIa contraindicated with 4 weeksBeware concurrent medicationsBeware concurrent medications
Little evidence increased surgical bleeding Little evidence increased surgical bleeding in non-cardiac studiesin non-cardiac studies
? Stop only to make epidural safer ? Stop only to make epidural safer (continue aspirin)(continue aspirin)
Usually on aspirin + clopidogrel because Usually on aspirin + clopidogrel because of intracoronary stentof intracoronary stent
Drug eluting stentsDrug eluting stents
Stop intimal hyperplasia which leads to early Stop intimal hyperplasia which leads to early occlusionocclusion
Delay epithelialisation – hence need long term Delay epithelialisation – hence need long term antiplatelet Rxantiplatelet Rx
Stopping antiplatelet Rx before surgery may Stopping antiplatelet Rx before surgery may increase risk of infarctincrease risk of infarct (combine hypercoagulable state+ (combine hypercoagulable state+ poorly endothelialised stent)poorly endothelialised stent)
Weigh benefit of epidural Weigh benefit of epidural (and less(and less surgical bleeding)surgical bleeding) v v ischaemia/infarctischaemia/infarct
? Combine the two ? After platelet function? Combine the two ? After platelet function
? Platelet? Plateletfunction monitoringfunction monitoring
Spectrum of response to RxSpectrum of response to RxCan we identify which patients are higher Can we identify which patients are higher
risk?risk?Bleeding timeBleeding timeOptical light transmission aggregometryOptical light transmission aggregometryPlatelet function analyserPlatelet function analyserModified TEG Modified TEG (Agarwal; Anaesthesiology 2006)(Agarwal; Anaesthesiology 2006)
Anti Xa fondaparinuxAnti Xa fondaparinux
Synthetic pentasaccharide, pure anti XaSynthetic pentasaccharide, pure anti Xa 15hr half life15hr half life Less venous thromboembolic events than with Less venous thromboembolic events than with
LMWH in orthopaedic patientsLMWH in orthopaedic patients Increased bleedingIncreased bleeding Administered post-op (6hrs)Administered post-op (6hrs) No studies with indwelling epidural cathetersNo studies with indwelling epidural catheters Haematoma risk unclearHaematoma risk unclear
Thrombin inhibitorsThrombin inhibitors
Recombinant hirudin dreivatives.Recombinant hirudin dreivatives. Inhibit free and clot bound thrombinInhibit free and clot bound thrombinArgatobatran (L arginine derivative) similar Argatobatran (L arginine derivative) similar
actionactionNo case reports spinal haematomaNo case reports spinal haematomaReports of spontaneous intracerebral Reports of spontaneous intracerebral
bleedbleedNo risk assessment statement given!No risk assessment statement given!
For each individual patient a clear drug For each individual patient a clear drug history is needed, an assessment of history is needed, an assessment of medical and surgical risk for their medical and surgical risk for their procedure, and an assessment of the procedure, and an assessment of the additional benefit of a regional anaesthetic additional benefit of a regional anaesthetic technique versus the risk of an epidural technique versus the risk of an epidural haematoma. In every patient undergoing a haematoma. In every patient undergoing a regional technique, rigorous post-op regional technique, rigorous post-op neurological monitoring is essential.neurological monitoring is essential.
Questions?Questions?